The Rise of Cell-Based Therapies in Anti-Aging and Neurodegenerative Healthcare Markets
The Rise of Cell-Based Therapies in Anti-Aging and Neurodegenerative Healthcare Markets
Cell-based therapies are rapidly emerging as a transformative force in the healthcare landscape. With a focus on cellular repair and regeneration, researchers are reshaping treatment paradigms by shifting from symptom management to potentially reversing damage associated with aging and chronic diseases.
A New Era in Healthcare
Instead of just addressing symptoms of aging, significant advancements in cell-based therapies aim to rejuvenate tissues and combat the fundamental causes of age-related deterioration. The field is particularly witnessing an increased interest from biotech companies and investors, which is reflected in the nearly $4.7 billion valuation of the global cell therapy market in 2023. Projections suggest this figure could soar beyond $20 billion by 2030, highlighting the potential for commercialization of innovative therapies.
In the anti-aging arena, stem cells and regenerative biologics are at the forefront of research. Scientists are exploring senolytic therapies that selectively eliminate senescent (often termed
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.